Female-specific risk of Alzheimer's disease is associated with tau phosphorylation processes: a transcriptome-wide interaction analysis

Cáceres, Alejandro; González Ruiz, Juan Ramón

doi:http://dx.doi.org/10.1016/j.neurobiolaging.2020.08.020

Female-specific risk of Alzheimer's disease is associated with tau phosphorylation processes: a transcriptome-wide interaction analysis

Citation

Cáceres A, González JR. Female-specific risk of Alzheimer's disease is associated with tau phosphorylation processes: a transcriptome-wide interaction analysis. Neurobiol Aging. 2020 Dec; 96: 104-108. DOI: 10.1016/j.neurobiolaging.2020.08.020

Abstract

The levels of tau phosphorylation differ between sexes in Alzheimer's disease (AD). Transcriptome-wide associations of sex by disease interaction could indicate whether specific genes underlie sex differences in tau pathology; however, no such study has been reported yet. We report the first analysis of the effect of the interaction between disease status and sex on differential gene expression, meta-analyzing transcriptomic data from the 3 largest publicly available case-control studies (N = 785) in the brain to date. A total of 128 genes, significantly associated with sex-AD interactions, were enriched in phosphoproteins (false discovery rate (FDR) = 0.001). High and consistent associations were found for the overexpressions of NCL (FDR = 0.002), whose phosphorylated protein generates an epitope against neurofibrillary tangles and KIF2A (FDR = 0.005), a microtubule-associated motor protein gene. Transcriptome-wide interaction analyses suggest sex-modulated tau phosphorylation, at sites like Thr231, Ser199, or Ser202 that could increase the risk of women to AD and indicate sex-specific strategies for intervention and prevention.